On February 15, 2022, Neurologypublished new research co-authored by AFAR grantee Randall J. Bateman, MD, that developed a blood test that has proven highly accurate in detecting early signs of Alzheimer’s disease.
Dr. Bateman is a 1997 Glenn/AFAR Scholarships for Research in the Biology of Aging recipient, a 2007 Paul B. Beeson Emerging Leaders Career Development Award in Aging recipient, and a 2015 MetLife Foundation Awards for Medical Research in Alzheimer’s Disease recipient. He is a Charles F. and Joanne Knight Distinguished Professor of Neurology and the Director of the Dominantly Inherited Alzheimer Network Trails Unit at the Washington University School of Medicine in St. Louis.
Read the research, “Validation of Plasma Amyloid- β 42/40 for Detecting Alzheimer Disease Amyloid Plaques,” here.
Read a related press release here.
